Our CEO Dr Bignold, and our CSO Dr Johnson, recently published an invited editorial on the role of the CXCL12-CXCR4 pathway in chronic obstructive pulmonary disease (COPD) in the American Journal of Respiratory Cell and Molecular Biology.
Read more here: